The AIMP1 Gene Leukodystrophy Hypomyelinating Type 3 NGS Genetic DNA Test is a crucial diagnostic tool designed to identify genetic mutations associated with neurological disorders.this test is essential for individuals showing symptoms of leukodystrophy and provides valuable insights for treatment planning. With a turnaround time of 3 to 4 weeks, patients can expect timely results.
